12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF

NCT02605304 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

NETWORK

Sponsor class

Stopped The study experienced enrollment difficulties.

Conditions

HIV-1 Infection
Hepatitis C

Interventions

DRUG: Ledipasvir/sofosbuvir
DRUG: Ribavirin

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Collaborators

[object Object]